India-made vaccines playing key role in making world free from Covid: Prez

President Ram Nath Kovind on Monday said that 'Made in India' Covid-19 vaccines are playing an important role in making the world free from the pandemic.

Kovind
ANI General News
2 min read Last Updated : Jan 31 2022 | 11:48 AM IST

President Ram Nath Kovind on Monday said that 'Made in India' COVID-19 vaccines are playing an important role in making the world free from the pandemic.

"COVID-19 vaccines being made in India are playing an important role in making the whole world free from the pandemic and saving the lives of crores of people," President Kovind in his address to the joint sitting of the Parliament at Central Hall on the first day of Budget session.

Lauding the efforts of the state governments, central government, administrations, healthcare workers, frontline workers to curb COVID-19, the President said that everyone worked as a team.

"India's capability in the fight against COVID-19 was evident in the vaccination programme. In less than a year, we made a record of administering over 150 crore doses of vaccine. Today, we are one of the leading nations of the world in terms of administering the maximum number of doses," the President said.

President Kovind said that over 90 per cent of adult citizens in the country have received the first dose of the vaccine, while more than 70 per cent have received both doses.

Notably, India's nationwide COVID-19 vaccination drive was started on January 16, 2021, and the vaccination coverage has exceeded 166.03 crores to date.

With the Budget Session of Parliament commencing on Monday, the government is all set to lay Economic Survey 2021-22 along with Statistical Appendix in both Houses.

Economic Survey 2021-22 and the Statistical Appendix will be laid on the table of the Lok Sabha at around 12.45 pm by Union Finance Minister Nirmala Sitharaman while it will be tabled in Upper House a few minutes after the House assembles at 2.30 pm.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusRam Nath Kovind

First Published: Jan 31 2022 | 11:48 AM IST

Next Story